Cargando…

Cost-effectiveness of SQ(®) HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany

BACKGROUND: Allergic rhinitis is a global health problem that burdens society due to associated health care costs and its impact on health. Standardized quality (SQ(®)) house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is a sublingually administered allergy immunotherapy tablet for patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, William, Kleine-Tebbe, Jörg, Klimek, Ludger, Hahn-Pedersen, Julie, Nørgaard Andreasen, Jakob, Taylor, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317265/ https://www.ncbi.nlm.nih.gov/pubmed/28243132 http://dx.doi.org/10.2147/CEOR.S115931

Ejemplares similares

Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting
por: Hahn-Pedersen, J., et al.
Publicado: (2016)

The SQ HDM SLIT‐Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A “real‐life” French study
por: Demoly, Pascal, et al.
Publicado: (2022)

A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax(®)) in House Dust Mite Allergic Rhinitis With or Without Asthma
por: Sidenius, Kirsten, et al.
Publicado: (2021)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

Cost-Effectiveness Of The SQ(®) Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective
por: Vogelberg, Christian, et al.
Publicado: (2019)

Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust
por: Lim, Fang Lee, et al.
Publicado: (2015)

New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ(®) tablets
por: Vitiello, Gianfranco, et al.
Publicado: (2020)

SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma
por: Blumberga, G, et al.
Publicado: (2011)

House dust mite (HDM) and storage mite (SM) molecular sensitisation profiles and association with clinical outcomes in allergic asthma and rhinitis: protocol for a systematic review
por: Matos-Semedo, Filipa, et al.
Publicado: (2021)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
por: Ellis, Anne K., et al.
Publicado: (2019)

Prevalence and Clinical Characteristics of Local Allergic Rhinitis to House Dust Mites
por: Jung, Chang-Gyu, et al.
Publicado: (2017)

Eustachian tube dysfunction in patients with house dust mite-allergic rhinitis
por: Ma, Yun, et al.
Publicado: (2020)

Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children
por: Lim, Jae Hyun, et al.
Publicado: (2017)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022)

Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma
por: HUI, YU, et al.
Publicado: (2014)

A 4-Week Model of House Dust Mite (HDM) Induced Allergic Airways Inflammation with Airway Remodeling
por: Woo, L. N., et al.
Publicado: (2018)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis
por: Gelardi, Matteo, et al.
Publicado: (2018)

TSLP receptor is not essential for house dust mite-induced allergic rhinitis in mice
por: Nakanishi, Wakako, et al.
Publicado: (2016)

Could FeNO Predict Asthma in Patients with House Dust Mites Allergic Rhinitis?
por: Muntean, Ioana Adriana, et al.
Publicado: (2020)

Allergic Rhinitis and House Dust Mite Sensitization Determine Persistence of Asthma in Children
por: Brzozowska, A., et al.
Publicado: (2022)

O17 - Assessment of efficacy and safety of sublingual tablets of house dust mite allergen extract in children and adolescents with allergic rhinitis
por: Halken, Susanne, et al.
Publicado: (2014)

Tropomyosin in mugwort cross-reacts to house dust mite, eliciting non-Th2 response in allergic rhinitis patients sensitized to house dust mite
por: Duan, Su, et al.
Publicado: (2021)

Berberine reduce allergic inflammation in a house dust mite allergic rhinitis mouse model
por: Kim, Soo Whan
Publicado: (2015)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children
por: Leger, Damien, et al.
Publicado: (2017)

IL-25 Could Be Involved in the Development of Allergic Rhinitis Sensitized to House Dust Mite
por: Kim, Dae Woo, et al.
Publicado: (2017)

A Cost-Utility Analysis of SQ(®) Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective
por: Pollock, Richard F, et al.
Publicado: (2023)

Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis
por: Kim, Sae-Hoon, et al.
Publicado: (2018)

Brain activation after nasal histamine provocation in house dust mite allergic rhinitis patients
por: Callebaut, Ina, et al.
Publicado: (2020)

Exposure to House Dust Mite Allergen and Endotoxin in Early Life and Sensitization and Allergic Rhinitis: The JECS
por: Kojima, Reiji, et al.
Publicado: (2022)

Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
por: Rieker-Schwienbacher, Juliane, et al.
Publicado: (2013)

Regulation of Constitutive Neutrophil Apoptosis Due to House Dust Mite Allergen in Normal and Allergic Rhinitis Subjects
por: Kim, Eun Hye, et al.
Publicado: (2014)

IL-33, but Not IL-25, Is Crucial for the Development of House Dust Mite Antigen-Induced Allergic Rhinitis
por: Nakanishi, Wakako, et al.
Publicado: (2013)

Elevated Levels of Activated and Pathogenic Eosinophils Characterize Moderate-Severe House Dust Mite Allergic Rhinitis
por: Chen, Yang, et al.
Publicado: (2020)

Strain-Specific Differences in House Dust Mite (Dermatophagoides farinae)-Induced Mouse Models of Allergic Rhinitis
por: Lee, Ki-Il, et al.
Publicado: (2020)

Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children
por: Rattanamanee, Tipyapa, et al.
Publicado: (2022)

Validated allergen exposure chamber is plausible tool for the assessment of house dust mite‐triggered allergic rhinitis
por: Zemelka‐Wiacek, Magdalena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v54s8rea3nj3tgdvij00ep87os